Cyclodextrin-based star polymers as a versatile platform for nanochemotherapeutics: Enhanced entrapment and uptake of idarubicin

Colloids and Surfaces B: Biointerfaces

Volumn 129, Issue , 2015, Pages 30-38

  Nafee, N ^a,c   Hirosue, M ^a   Loretz, B ^b   Wenz, G ^a   Lehr, C M ^a,b  

^a SAARLAND UNIVERSITY   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

^c Alexandria University Faculty of Pharmacy   (Egypt)

Author keywords

Chemotherapy; Chitosan; Cyclodextrin; Idarubicin; Nanoparticles; Star copolymer

Indexed keywords

ACRYLIC MONOMERS; BIOCOMPATIBILITY; CELL CULTURE; CELLS; CHEMOTHERAPY; CHITIN; CHITOSAN; COPOLYMERS; CYCLODEXTRINS; CYTOLOGY; ENCAPSULATION; ESTERS; HYDROPHOBICITY; MOBILE SECURITY; MOLECULAR WEIGHT DISTRIBUTION; NANOPARTICLES;

CONCENTRATION-DEPENDENT; ENCAPSULATION EFFICIENCY; IDARUBICIN; NARROW MOLECULAR WEIGHT DISTRIBUTIONS; NEGATIVE ZETA POTENTIALS; POSITIVE SURFACE CHARGE; PREFERENTIAL LOCALIZATION; STAR COPOLYMERS;

POLYMERS;

BETA CYCLODEXTRIN; IDARUBICIN; LACTATE DEHYDROGENASE; METHACRYLIC ACID METHYL ESTER TERT BUTYL ACRYLATE POLYMER; NANOPARTICLE; POLYMER; UNCLASSIFIED DRUG; ANTINEOPLASTIC ANTIBIOTIC; CELLULOSE; CHITOSAN; CYCLODEXTRIN; CYCLODEXTRIN POLYMER; DRUG CARRIER; MACROGOL DERIVATIVE;

A549 CELL LINE; ARTICLE; CACO 2 CELL LINE; CELLULAR DISTRIBUTION; COLLOID; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DRUG RELEASE; DRUG UPTAKE; MOLECULAR STABILITY; MOLECULAR WEIGHT; MTT ASSAY; NANOENCAPSULATION; PARTICLE SIZE; PH; POLYMERIZATION; PRIORITY JOURNAL; SURFACE CHARGE; SURFACE PROPERTY; ZETA POTENTIAL; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; HUMAN; LUNG NEOPLASMS; METABOLISM; NANOTECHNOLOGY; PATHOLOGY; TUMOR CELL CULTURE;

ANTIBIOTICS, ANTINEOPLASTIC; CACO-2 CELLS; CELL SURVIVAL; CELLULOSE; CHITOSAN; CYCLODEXTRINS; DRUG CARRIERS; HUMANS; IDARUBICIN; L-LACTATE DEHYDROGENASE; LUNG NEOPLASMS; NANOPARTICLES; NANOTECHNOLOGY; PARTICLE SIZE; POLYETHYLENE GLYCOLS; TUMOR CELLS, CULTURED;

EID: 84925423033     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2015.03.014     Document Type: Article

References (44)

1. Rasheed A., Ashok Kumar C.K., Sravanthi V.V.N.S.S. Cyclodextrins as drug carrier molecule: a review. Sci. Pharm. 2008, 76:567-598.
2. Badruddoza A.Z.M., Rahman M.T., Ghosh S., Hossain M.Z., Shi J., Hidajat K., Uddin M.S. β-Cyclodextrin conjugated magnetic, fluorescent silica core-shell nanoparticles for biomedical applications. Carbohydr. Polym. 2013, 95:449-457.
3. Zhang J., Ma P.X. Cyclodextrin-based supramolecular systems for drug delivery: recent progress and future perspective. Adv. Drug Deliv. Rev. 2013, 65:1215-1233.
4. Dhule S.S., Penfornis P., Frazier T., Walker R., Feldman J., Tan G., He J., Alb A., John V., Pochampally R. Curcumin-loaded γ-cyclodextrin liposomal nanoparticles as delivery vehicles for osteosarcoma. Nanomed. Nanotechnol. Biol. Med. 2012, 8:440-451.
5. Pizzimenti S., Ciamporcero E., Pettazzoni P., Osella-Abate S., Novelli M., Toaldo C., Husse M., Daga M., Minelli R., Bisazza A., Ferruti P., Ranucci E., Grazia Bernengo M., Dianzani C., Biasi F., Cavalli R., Barrera G. The inclusion complex of 4-hydroxynonenal with a polymeric derivative of β-cyclodextrin enhances the antitumoral efficacy of the aldehyde in several tumor cell lines and in a three-dimensional human melanoma model. Free Radic. Biol. Med. 2013, 65:765-777.
6. Teuchert C., Michel C., Hausen F., Park D.-Y., Beckham H.W., Wenz G. Cylindrical polymer brushes by atom transfer radical polymerization from cyclodextrin-PEG polyrotaxanes: synthesis and mechanical stability. Macromolecules 2012, 46:2-7.
7. Bilensoy E., Hincal A.A. Recent advances and future directions in amphiphilic cyclodextrin nanoparticles. Expert Opin. Drug Deliv. 2009, 6:1161-1173.
8. Moutard S., Perly B., Godé P., Demailly G., Djedaïni-Pilard F. Novel glycolipids based on cyclodextrins. J. Incl. Phenom. Macrocycl. Chem. 2002, 44:317-322.
9. Sallas F., Darcy R. Amphiphilic cyclodextrins - advances in synthesis and supramolecular chemistry. Eur. J. Org. Chem. 2008, 957-969.
10. Angelova A., Fajolles C., Hocquelet C.l., Djedaïni-Pilard F., Lesieur S., Bonnet V.r., Perly B., Lebas G.v., Mauclaire L. Physico-chemical investigation of asymmetrical peptidolipidyl-cyclodextrins. J. Colloid Interface Sci. 2008, 322:304-314.
11. Lo Meo P., D'Anna F., Gruttadauria M., Riela S., Noto R. Synthesis and characterization of new polyamino-cyclodextrin materials. Carbohydr. Res. 2012, 347:32-39.
12. Gervaise C., Bonnet V., Wattraint O., Aubry F., Sarazin C., Jaffrés P.-A., Djedaini-Pilard F. Synthesis of lipophosphoramidyl-cyclodextrins and their supramolecular properties. Biochimie 2012, 94:66-74.
13. Kamigaito M., Ando T., Sawamoto M. Metal-catalyzed living radical polymerization. Chem. Rev. 2001, 101:3689-3746.
14. Li Y., Qian Y., Liu T., Zhang G., Hu J., Liu S. Asymmetrically functionalized [small beta]-cyclodextrin-based star copolymers for integrated gene delivery and magnetic resonance imaging contrast enhancement. Polym. Chem. 2014, 5:1743-1750.
15. Liu T., Li X., Qian Y., Hu X., Liu S. Multifunctional pH-disintegrable micellar nanoparticles of asymmetrically functionalized β-cyclodextrin-based star copolymer covalently conjugated with doxorubicin and DOTA-Gd moieties. Biomaterials 2012, 33:2521-2531.
16. Ouchi M., Terashima T., Sawamoto M. Transition metal-catalyzed living radical polymerization: toward perfection in catalysis and precision polymer synthesis. Chem. Rev. 2009, 109:4963-5050.
17. Uegaki H., Kotani Y., Kamigaito M., Sawamoto M. NiBr2(Pn-Bu3)2-mediated living radical polymerization of methacrylates and acrylates and their block or random copolymerizations1. Macromolecules 1998, 31:6756-6761.
18. Kuendgen A., Germing U. Emerging treatment strategies for acute myeloid leukemia (AML) in the elderly. Cancer Treat. Rev. 2009, 35:97-120.
19. Mays A.N., Osheroff N., Xiao Y., Wiemels J.L., Felix C.A., Byl J.A., Saravanamuttu K., Peniket A., Corser R., Chang C., Hoyle C., Parker A.N., Hasan S.K., Lo-Coco F., Solomon E., Grimwade D. Evidence for direct involvement of epirubicin in the formation of chromosomal translocations in t(15;17) therapy-related acute promyelocytic leukemia. Blood 2010, 115:326-330.
20. Gubernator J., Chwastek G., Korycińska M., Stasiuk M., Grynkiewicz G., Lewrick F., Süss R., Kozubek A. The encapsulation of idarubicin within liposomes using the novel EDTA ion gradient method ensures improved drug retention in vitro and in vivo. J. Control. Release 2010, 146:68-75.
21. Slifirski P., Szelejewski W., Grynkiewicz G., Gubernator J., Kozubek A. Liposomal formulation of idarubicin. Acta Pol. Pharm. 2003, 60:138-140.
22. Sermsappasuk P., Hrynyk R., Gubernator J., Weiss M. Reduced uptake of liposomal idarubicin in the perfused rat heart. Anticancer Drugs 2008, 19:729-732.
23. Nafee N., Taetz S., Schneider M., Schaefer U.F., Lehr C.M. Chitosan-coated PLGA nanoparticles for DNA/RNA delivery: effect of the formulation parameters on complexation and transfection of antisense oligonucleotides. Nanomed. Nanotechnol. Biol. Med. 2007, 3:173-183.
24. Chittasupho C., Xie S.-X., Baoum A., Yakovleva T., Siahaan T.J., Berkland C.J. ICAM-1 targeting of doxorubicin-loaded PLGA nanoparticles to lung epithelial cells. Eur. J. Pharm. Sci. 2009, 37:141-150.
25. Higashihara T., Hayashi M., Hirao A. Synthesis of well-defined star-branched polymers by stepwise iterative methodology using living anionic polymerization. Prog. Polym. Sci. 2011, 36:323-375.
26. Miura Y., Narumi A., Matsuya S., Satoh T., Duan Q., Kaga H., Kakuchi T. Synthesis of well-defined AB20-type star polymers with cyclodextrin-core by combination of NMP and ATRP. J. Polym. Sci. A: Polym. Chem. 2005, 43:4271-4279.
27. Xu J., Liu S. Synthesis of well-defined 7-arm and 21-arm poly(N-isopropylacrylamide) star polymers with β-cyclodextrin cores via click chemistry and their thermal phase transition behavior in aqueous solution. J. Polym. Sci. A: Polym. Chem. 2009, 47:404-419.
28. Diaz-Moscoso A., Guilloteau N., Bienvenu C., Méndez-Ardoy A., Jiménez Blanco J.L., Benito J.M., Le Gourriérec L., Di Giorgio C., Vierling P., Defaye J., Ortiz Mellet C., Garcia Fernandez J.M. Mannosyl-coated nanocomplexes from amphiphilic cyclodextrins and pDNA for site-specific gene delivery. Biomaterials 2011, 32:7263-7273.
29. Vrignaud S., Anton N., Gayet P., Benoit J.-P., Saulnier P. Reverse micelle-loaded lipid nanocarriers: a novel drug delivery system for the sustained release of doxorubicin hydrochloride. Eur. J. Pharm. Biopharm. 2011, 79:197-204.
30. Cavalli R., Caputo O., Gasco M.R. Solid lipospheres of doxorubicin and idarubicin. Int. J. Pharm. 1993, 89:R9-R12.
31. Siddiqui A., Gupta V., Liu Y.-Y., Nazzal S. Doxorubicin and MBO-asGCS oligonucleotide loaded lipid nanoparticles overcome multidrug resistance in adriamycin resistant ovarian cancer cells (NCI/ADR-RES). Int. J. Pharm. 2012, 431:222-229.
32. Wang Y., Chen L., Ding Y., Yan W. Oxidized phospholipid based pH sensitive micelles for delivery of anthracyclines to resistant leukemia cells in vitro. Int. J. Pharm. 2012, 422:409-417.
33. Jain R., Dandekar P., Loretz B., Melero A., Stauner T., Wenz G., Koch M., Lehr C.-M. Enhanced cellular delivery of idarubicin by surface modification of propyl starch nanoparticles employing pteroic acid conjugated polyvinyl alcohol. Int. J. Pharm. 2011, 420:147-155.
34. He Q., Wu W., Xiu K., Zhang Q., Xu F., Li J. Controlled drug release system based on cyclodextrin-conjugated poly(lactic acid)-b-poly(ethylene glycol) micelles. Int. J. Pharm. 2013, 443:110-119.
35. 2-assisted technology. Int. J. Pharm. 2009, 376:110-115.
36. Li J., Guo Z., Xin J., Zhao G., Xiao H. 21-Arm star polymers with different cationic groups based on cyclodextrin core for DNA delivery. Carbohydr. Polym. 2010, 79:277-283.
37. Liang B., Deng J.J., Yuan F., Yang N., Li W., Yin J.R., Pu S.X., Xie L.C., Gao C., Zhang L.M. Efficient gene transfection in the neurotypic cells by star-shaped polymer consisting of β-cyclodextrin core and poly(amidoamine) dendron arms. Carbohydr. Polym. 2013, 94:185-192.
38. Liu T., Xue W., Ke B., Xie M.-Q., Ma D. Star-shaped cyclodextrin-poly(l-lysine) derivative co-delivering docetaxel and MMP-9 siRNA plasmid in cancer therapy. Biomaterials 2014, 35:3865-3872.
39. Xiu K.M., Yang J.J., Zhao N.N., Li J.S., Xu F.J. Multiarm cationic star polymers by atom transfer radical polymerization from β-cyclodextrin cores: influence of arm number and length on gene delivery. Acta Biomater. 2013, 9:4726-4733.
40. Ge Z., Liu S. Functional block copolymer assemblies responsive to tumor and intracellular microenvironments for site-specific drug delivery and enhanced imaging performance. Chem. Soc. Rev. 2013, 42:7289-7325.
41. Nafee N., Schneider M., Friebel K., Dong M., Schaefer U.F., Mürdter T.E., Lehr C.M. Treatment of lung cancer via telomerase inhibition: self-assembled nanoplexes versus polymeric nanoparticles as vectors for 2'-O-methyl-RNA. Eur. J. Pharm. Biopharm. 2012, 80:478-489.
42. Sarmento B., Mazzaglia D., Bonferoni M.C., Neto A.P., do Céu Monteiro M., Seabra V. Effect of chitosan coating in overcoming the phagocytosis of insulin loaded solid lipid nanoparticles by mononuclear phagocyte system. Carbohydr. Polym. 2011, 84:919-925.
43. Davis M.E. The first targeted delivery of siRNA in humans via a self-assembling, cyclodextrin polymer-based nanoparticle: from concept to clinic. Mol. Pharm. 2009, 6:659-668.
44. He B., Lin P., Jia Z., Du W., Qu W., Yuan L., Dai W., Zhang H., Wang X., Wang J., Zhang X., Zhang Q. The transport mechanisms of polymer nanoparticles in Caco-2 epithelial cells. Biomaterials 2013, 34:6082-6098.